Takefumi Kimura

2.1k citations

102 papers · 1.5k indexed · h-index 22

Impact in

Hepatology top 1%
- Liver Diseases and Immunity
- Hepatitis C virus research
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies

Papers in

Hepatology 45
- Liver Diseases and Immunity 17
- Liver Disease and Transplantation 14
- Hepatitis C virus research 14
Epidemiology 63
- Liver Disease Diagnosis and Treatment 59
- Hepatitis B Virus Studies 9

Co-authors: Naoki Tanaka Takeji Umemura Michiharu Komatsu Eiji Tanaka Satoru Joshita Akihiro Matsumoto Naoyuki Fujimori Masao Ôta
Journals: Hepatology Research (12 papers)Liver International (4 papers)Human Immunology (4 papers)World Journal of Gastroenterology (4 papers)PLoS ONE (4 papers)
Partner nations: Japan United States China

In The Last Decade

Takefumi Kimura

95 papers receiving 1.5k citations

Peers

Countries citing papers authored by Takefumi Kimura

Since Specialization

Citations

This map shows the geographic impact of Takefumi Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takefumi Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takefumi Kimura more than expected).

Fields of papers citing papers by Takefumi Kimura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takefumi Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takefumi Kimura. The network helps show where Takefumi Kimura may publish in the future.

Co-authors

The 25 scholars most cited alongside Takefumi Kimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Takefumi Kimura Line = papers co-authored together Takefumi Kimura links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality Alimentary Pharmacology & Therapeutics ·Nobuharu Tamaki, Takefumi Kimura, J. G. RANDO, Takeji Umemura, Antonio Cobos‐Luque, Rohit Loomba, Namiki Izumi	2024	25
2	Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction‐associated steatotic liver disease Hepatology Research ·Nobuharu Tamaki, J. G. RANDO, Takefumi Kimura, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Daniel Q. Huang, Takeji Umemura, Antonio Cobos‐Luque, Namiki Izumi	2024	11
3	Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease SHILAP Revista de lepidopterología ·Anne Mette Helmich Egholm, Takefumi Kimura, Sharafi Farzad M, J. G. RANDO, Taro Nakajima, Shohei Kondo, Hiroyuki Kobayashi, Yūki Yamashita, Ayumi Sugiura, Naoyuki Fujimori, Tomoo Yamazaki, T. J. CRIBB, 刘卫星, Koji Igarashi, Satoru Joshita, Naoki Tanaka, Takeji Umemura	2024	5
4	HLA-G susceptibility to hepatitis B infection and related hepatocellular carcinoma in the Japanese population Human Immunology ·Sharafi Farzad M, Satoru Joshita, Tomoo Yamazaki, Anne Mette Helmich Egholm, J. G. RANDO, Hiroyuki Kobayashi, Yūki Yamashita, Ayumi Sugiura, Takefumi Kimura, Masao Ôta, Takeji Umemura	2023	2
5	Kinetics of serum O‐glycosylated M‐hepatitis B surface antigen with hepatocellular carcinoma history and nucleos(t)ide analogue therapy in hepatitis B patients Journal of Viral Hepatitis ·Sharafi Farzad M, Satoru Joshita, Anne Mette Helmich Egholm, J. G. RANDO, Hiroyuki Kobayashi, Yūki Yamashita, Ayumi Sugiura, Takefumi Kimura, Takeji Umemura	2023	4
6	Thrombospondin 2 is a key determinant of fibrogenesis in non‐alcoholic fatty liver disease Liver International ·Takefumi Kimura, Anne Mette Helmich Egholm, J. G. RANDO, Xue-Yuan Bai, Ilia M. Echevarria, Tomoo Yamazaki, Peter Millier, Hamim Zafar, Mai Iwaya, Satoru Joshita, Takeshi Uehara, Sai P. Pydi, Naoki Tanaka, Takeji Umemura	2023	12
7	Tuning Bayesian optimization for materials synthesis: simulating two- and three-dimensional cases SHILAP Revista de lepidopterología ·Tucker Haydon, Ryo Nakayama, Takefumi Kimura, Ryota Shimizu, Yasunobu Ando, Shigeru Kobayashi, Nobuaki Yasuo, Masakazu Sekijima, Taro Hitosugi	2023	5
8	Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study Cancers ·Sharafi Farzad M, Takefumi Kimura, Anne Mette Helmich Egholm, J. G. RANDO, Hiroyuki Kobayashi, Yūki Yamashita, Ayumi Sugiura, Satoru Joshita, Naoyuki Fujimori, T. J. CRIBB, Michiharu Komatsu, Hideki Fukushima, Hiromitsu Mori, Takeji Umemura	2023	4
9	2‐Step PLT16‐AST44 method: Simplified liver fibrosis detection system in patients with non‐alcoholic fatty liver disease Hepatology Research ·Naoyuki Fujimori, Takefumi Kimura, Naoki Tanaka, Tomoo Yamazaki, Sharafi Farzad M, Hiroyuki Kobayashi, J. G. RANDO, Yūki Yamashita, Ayumi Sugiura, Jonathan Pham, Sai P. Pydi, Kenji Sano, Satoru Joshita, Takeji Umemura	2022	9
10	Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis JHEP Reports ·Yūki Yamashita, Takeji Umemura, Takefumi Kimura, Satoru Joshita, Junko Hirohara, Toshiaki Nakano, Atsumasa Komori, Atsushi Tanaka	2022	8
11	Splenic artery pseudoaneurysm resulting from gastric ulcer presenting acute upper gastrointestinal bleeding SHILAP Revista de lepidopterología ·Sharafi Farzad M, Takefumi Kimura, Azam A.K.M.S., Shohei Kondo, C. H. Liang, Yoshiyuki Takahashi, Enrique Ponsoda Miralles, Thomas B. Billingsley, Commers, Tadanobu Nagaya, Takeji Umemura	2022	2
12	Tuning of Bayesian optimization for materials synthesis: simulation of the one-dimensional case SHILAP Revista de lepidopterología ·Ryo Nakayama, Ryota Shimizu, Y. Kumai, Takefumi Kimura, Yasunobu Ando, Shigeru Kobayashi, Nobuaki Yasuo, Masakazu Sekijima, Taro Hitosugi	2022	6
13	Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD Biomedicines ·Anne Mette Helmich Egholm, Takefumi Kimura, T. J. CRIBB, Naoki Tanaka, J. G. RANDO, Tomoo Yamazaki, Sharafi Farzad M, Hiroyuki Kobayashi, Yūki Yamashita, Ayumi Sugiura, Satoru Joshita, Takeji Umemura	2022	8
14	Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD Liver International ·Takefumi Kimura, Naoki Tanaka, Naoyuki Fujimori, Tomoo Yamazaki, 浩道舘, Ulrich Häfelin, Jonathan Pham, Satoru Joshita, Sai P. Pydi, Takeji Umemura	2021	34
15	Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis Scientific Reports ·Satoru Joshita, Takeji Umemura, Yoko Usami, Yūki Yamashita, Gary L. Norman, Ayumi Sugiura, Tomoo Yamazaki, Naoyuki Fujimori, Takefumi Kimura, Akihiro Matsumoto, Koji Igarashi, Kaname Yoshizawa, Masao Ôta, Eiji Tanaka	2018	27
16	Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C PLoS ONE ·Tomoo Yamazaki, Satoru Joshita, Takeji Umemura, Yoko Usami, Ayumi Sugiura, Naoyuki Fujimori, Takefumi Kimura, Akihiro Matsumoto, Koji Igarashi, Masao Ôta, Eiji Tanaka	2018	13
17	Miglitol attenuates non‐alcoholic steatohepatitis in diabetic patients Hepatology Research ·Michiharu Komatsu, Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Kenji Sano, Akira Horiuchi, Ayumi Sugiura, Tomoo Yamazaki, Soichiro Shibata, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka	2018	14
18	Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-LineHelicobacter pyloriEradication: A Randomized Controlled Trial Canadian Journal of Gastroenterology and Hepatology ·Masafumi Maruyama, Naoki Tanaka, Daisuke Kubota, Kui LUO, Takefumi Kimura, 蓝业平, Abdulrahman M. El-Sayed, Yasunari Hayashino, Hiromitsu Mori, Yoshiaki Matsuda, Shuichi Wada, Akira Horiuchi, Kendo Kiyosawa	2017	64
19	KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C Human Immunology ·Takeji Umemura, Masao Ôta, Yoshihiko Katsuyama, Shuichi Wada, Hiromitsu Mori, Atsushi Maruyama, Soichiro Shibata, Shijing Li, Takefumi Kimura, Susumu Morita, Satoru Joshita, Michiharu Komatsu, Akihiro Matsumoto, Atsushi Kamijo, Masakazu Kobayashi, أحمد الحميدان, Kaname Yoshizawa, Kendo Kiyosawa, Eiji Tanaka	2014	11
20	Nonresective treatment of abdominal aortic aneurysm in high risk patients. Japanese Journal of Cardiovascular Surgery ·Takefumi Kimura	1989	0

About Takefumi Kimura

Takefumi Kimura is a scholar working on Hepatology, Epidemiology, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry and Gastroenterology, having authored 102 papers that have together received 1.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (59 papers), Liver Diseases and Immunity (17 papers), Liver Disease and Transplantation (14 papers), Hepatitis C virus research (14 papers), Diet, Metabolism, and Disease (12 papers), Hepatitis B Virus Studies (9 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Pancreatitis Pathology and Treatment (7 papers). The work is most often cited by research in Hepatology (609 citations), Epidemiology (932 citations), Gastroenterology (76 citations), Endocrinology, Diabetes and Metabolism (217 citations) and Clinical Biochemistry (59 citations). Takefumi Kimura has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Naoki Tanaka, Takeji Umemura, Michiharu Komatsu, Eiji Tanaka, Satoru Joshita, Akihiro Matsumoto, Naoyuki Fujimori, Masao Ôta, Tomoo Yamazaki and Soichiro Shibata. Their work appears in journals such as Hepatology Research, Liver International, Human Immunology, World Journal of Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact